Managed Healthcare Executive

GLP-1s outdo aspirin in colorectal cancer prevention, study finds | ASCO Gastrointestinal Cancers Symposium

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
WVEC

VERIFY: The two ways to calculate how much your risk is reduced by getting the COVID vaccines

WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Business Wire

Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25 percent in adults with and without diabetes who had heart ...

INGELHEIM, Germany and INDIANAPOLIS--(BUSINESS WIRE)--Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, ...
Science Daily

Study finds statins reduce the relative risk of cardiovascular diseases by over 20% in adults aged 75+ with high cholesterol

Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
The New England Journal of Medicine

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

O’Brien et al. report that the combination of casirivimab and imdevimab (REGEN-COV) reduced the risk of symptomatic Covid-19 by 81.4% among persons exposed to SARS-CoV-2. 1 However, we question the ...